Safety and Efficacy of CD19 CAR-T Therapy for Recurrent/Refractory Autoimmune Diseases

NCT06983964 · clinicaltrials.gov ↗
NA
Phase
RECRUITING
Status
12
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Beijing Boren Hospital